Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Accounts Payables: 2010-2025

Historic Accounts Payables for Exponent (EXPO) over the last 15 years, with Oct 2025 value amounting to $26.5 million.

  • Exponent's Accounts Payables rose 16.81% to $26.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $26.5 million, marking a year-over-year increase of 16.81%. This contributed to the annual value of $22.1 million for FY2025, which is 0.05% up from last year.
  • Per Exponent's latest filing, its Accounts Payables stood at $26.5 million for Q4 2025, which was up 4.69% from $25.3 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Accounts Payables ranged from a high of $36.8 million in Q2 2025 and a low of $16.3 million during Q1 2021.
  • In the last 3 years, Exponent's Accounts Payables had a median value of $22.6 million in 2024 and averaged $24.3 million.
  • In the last 5 years, Exponent's Accounts Payables skyrocketed by 67.51% in 2022 and then plummeted by 38.29% in 2023.
  • Quarterly analysis of 5 years shows Exponent's Accounts Payables stood at $24.5 million in 2021, then grew by 18.82% to $29.1 million in 2022, then decreased by 24.01% to $22.1 million in 2023, then rose by 15.31% to $22.6 million in 2024, then rose by 16.81% to $26.5 million in 2025.
  • Its Accounts Payables stands at $26.5 million for Q4 2025, versus $25.3 million for Q3 2025 and $36.8 million for Q2 2025.